Stay updated on Pembrolizumab in Anaplastic Thyroid Cancer Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab in Anaplastic Thyroid Cancer Clinical Trial page.

Latest updates to the Pembrolizumab in Anaplastic Thyroid Cancer Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedThe web page has been updated from version 2.16.11 to version 2.16.12.SummaryDifference0.1%
- Check20 days agoChange DetectedThe web page has been updated from version 2.16.10 to version 2.16.11.SummaryDifference0.1%
- Check27 days agoChange DetectedThe page has been updated to version v2.16.10, and a previous service alert regarding planned maintenance has been removed.SummaryDifference1.0%
- Check34 days agoChange DetectedThe page has been updated to reflect a new version, changing from Revision v2.16.6 to v2.16.8, and includes a new section on HHS Vulnerability Disclosure.SummaryDifference0.2%
- Check41 days agoChange DetectedThe web page has been updated from version 2.16.5 to version 2.16.6.SummaryDifference0.1%
- Check49 days agoChange DetectedA service alert has been added indicating planned maintenance starting July 25th, during which most services will be unavailable for over 24 hours.SummaryDifference0.9%
Stay in the know with updates to Pembrolizumab in Anaplastic Thyroid Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Anaplastic Thyroid Cancer Clinical Trial page.